Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières (MSF), Epicentre and The Norwegian Institute of Public Health (NIPH), will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
The vaccine was developed by the Public Health Agency of Canada. A second vaccine will be tested in a sequential study, as supply becomes available.
Nigeria introduces the inactivated polio vaccine into routine immunization programme
In February 2015, Nigeria became the first polio endemic country to introduce the inactivated polio vaccine (IPV) into its routine immunization programme. The Minister of Health, Dr Alhassan Khaliru, described the introduction as “a quantum-leap opportunity for Nigeria in the polio eradication endgame strategy”.
The introduction of IPV into routine immunization programmes is one of the four major objectives of the Global Polio Eradication Initiative (GPEI). In May 2012, the World Health Assembly called on all countries using only the oral polio vaccine (OPV) to introduce at least one dose of IPV into routine immunization schedules by the end of 2015. This is the largest globally coordinated vaccine introduction project in history.
WHO updates position paper on Japanese encephalitis vaccines
An updated position paper on Japanese encephalitis (JE) vaccines published in today’s edition of the Weekly Epidemiological Record focuses on new information concerning the availability, safety, immunogenicity, and effectiveness of JE vaccines and the duration of protection they confer. This updated version replaces the 2006 JE vaccines position paper.
Progress report on the Millennium Development Goals
A Global Child Health event organized by the Archives of Disease in Childhood (ADC) is taking place today in London. The event coincides with the launch of the ADC supplement on Millennium Development Goals: Progress Reports. The supplement reflects on the progress made towards the achievement of the MDGs, with particular respect to child health.
Included in the supplement is an article focusing on the contribution by Gavi, the Vaccine Alliance in reducing child mortality. The article was co-authored by Dr Jean-Marie Okwo-Bele and Lidija Kamara from the WHO Department of Immunization, vaccines and biologicals and Dr Flavia Bustreo, WHO Assistant-Director General of Family, women’s and children’s health.
75%drop in global measles deathsGlobal progress towards regional measles elimination
84%of infants vaccinated with 3 doses of DTP vaccine in 2013Immunization coverage fact sheet
21.8 millioninfants still missing out on basic vaccinesGlobal routine vaccination coverage 2013